Immunogenicity of the mRNA-1273 and ChAdOx1 nCoV-19 vaccines in Asian patients with autoimmune rheumatic diseases under biologic and/or conventional immunosuppressant treatments.
Hsien-Tzung LiaoH-Y TungC-T ChouHung-Cheng TsaiYi-Ning YenChang-Youh TsaiPublished in: Scandinavian journal of rheumatology (2022)
mRNA-1273 and ChAdOx1 nCoV-19 vaccines were immunogenic in the majority of ARD patients. Rituximab and abatacept were associated with significantly diminished COVID-19 vaccination immunogenicity.
Keyphrases
- rheumatoid arthritis
- end stage renal disease
- newly diagnosed
- coronavirus disease
- ejection fraction
- sars cov
- chronic kidney disease
- multiple sclerosis
- peritoneal dialysis
- diffuse large b cell lymphoma
- prognostic factors
- patient reported outcomes
- systemic lupus erythematosus
- hodgkin lymphoma
- disease activity
- chronic lymphocytic leukemia